AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32014686 — intervention group
Group type: COMPARATOR
Intervention: Dendritic cell (DC) vaccination alone
Number of subjects: 0
Study 32014686 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose systemic interferon-α2b (HDI)
Number of subjects: 0
Study 35654568 — intervention group
Group type: EXPERIMENTAL
Intervention: 4EO mouthrinse
Number of subjects: 156
Study 35654568 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional flossing (FBH)
Number of subjects: 156
Study 35654568 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised self-flossing (FUS)
Number of subjects: 156
Study 35654568 — intervention group
Group type: COMPARATOR
Intervention: Negative control (NC)
Number of subjects: 156
Study 32542695 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 76
Study 32542695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32028480 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroabrasion treatment on half of the wound
Number of subjects: 24
Study 32028480 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated half of the wound)
Number of subjects: 24
Study 32028480 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroabrasion treatment
Number of subjects: 24
Study 36452984 — intervention group
Group type: EXPERIMENTAL
Intervention: Big blades with Randall foils
Number of subjects: 20
Study 36452984 — intervention group
Group type: COMPARATOR
Intervention: Big blades without Randall foils
Number of subjects: 20
Study 33802272 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (Curcuma longa)
Number of subjects: 20
Study 33802272 — intervention group
Group type: COMPARATOR
Intervention: Boswellia (Boswellia serrata)
Number of subjects: 20
Study 33802272 — intervention group
Group type: COMPARATOR
Intervention: French Maritime Pine Bark (Pinus pinaster)
Number of subjects: 20
Study 35960394 — intervention group
Group type: EXPERIMENTAL
Intervention: HNC Virtual Coach
Number of subjects: 0
Study 35960394 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care and paper logs
Number of subjects: 0
Study 33954839 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT)
Number of subjects: 1852
Study 33954839 — intervention group
Group type: COMPARATOR
Intervention: Low-flow oxygen (LFO)
Number of subjects: 1852
Study 33954839 — intervention group
Group type: COMPARATOR
Intervention: Permissive hypoxaemia
Number of subjects: 1852
Study 33954839 — intervention group
Group type: COMPARATOR
Intervention: Liberal vs permissive comparison
Number of subjects: 1852
Study 33954839 — intervention group
Group type: COMPARATOR
Intervention: HFNT vs LFO comparison
Number of subjects: 1852
Study 33954839 — intervention group
Group type: COMPARATOR
Intervention: Strata-specific 28 day mortality rates
Number of subjects: 1852
Study 33954839 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive sequelae
Number of subjects: 1852
Study 35634695 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic containing Lactobacillus rhamnosus HN001™, Lactobacillus paracasei Lpc‐37®, and Bifidobacterium animalis subsp lactis HN019™
Number of subjects: 36
Study 35634695 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic
Number of subjects: 36
Study 35634695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 34972869 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated dual-task training (IDTT) for 8 weeks
Number of subjects: 58
Study 34972869 — intervention group
Group type: COMPARATOR
Intervention: Consecutive dual-task training (CDTT) for 8 weeks
Number of subjects: 58
Study 33570801 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal counselling plus audio feedback (ordinary Clip-tone®)
Number of subjects: 200
Study 33570801 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal counselling plus audio and visual feedback (Clip-tone® with smartphone application)
Number of subjects: 200
Study 33570801 — intervention group
Group type: COMPARATOR
Intervention: Verbal counselling only
Number of subjects: 200
Study 33570801 — intervention group
Group type: COMPARATOR
Intervention: Verbal counselling with resistance (modified Clip-tone®)
Number of subjects: 200
Study 32731259 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Number of subjects: 201
Study 32731259 — intervention group
Group type: COMPARATOR
Intervention: Ibrutinib
Number of subjects: 201
Study 34768124 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV clinic‐based buprenorphine (BUP/NX)
Number of subjects: 264
Study 34768124 — intervention group
Group type: COMPARATOR
Intervention: Methadone maintenance therapy (MMT)
Number of subjects: 264
Study 34456060 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal varenicline 0.12 mg in OC‐01 nasal spray
Number of subjects: 22
Study 34456060 — intervention group
Group type: COMPARATOR
Intervention: Oral varenicline 1 mg
Number of subjects: 22
Study 35019018 — intervention group
Group type: EXPERIMENTAL
Intervention: Aesthetic pre-evaluative temporary technique (group A)
Number of subjects: 6
Study 35019018 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique (group T)
Number of subjects: 6
Study 36380332 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted hypothermia (33 °C)
Number of subjects: 1592
Study 36380332 — intervention group
Group type: COMPARATOR
Intervention: Normothermia with early treatment of fever (body temperature, ≥37.8 °C)
Number of subjects: 1592
Study 33386046 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based motor rehabilitation (12 sessions, 40 minutes, 3 times a week for 4 weeks)
Number of subjects: 37
Study 33386046 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (12 sessions, 40 minutes, 3 times a week for 4 weeks)
Number of subjects: 37
Study 33582788 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio ads
Number of subjects: 568
Study 33582788 — intervention group
Group type: EXPERIMENTAL
Intervention: TV interviews
Number of subjects: 568
Study 33582788 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media posts
Number of subjects: 568
Study 33582788 — intervention group
Group type: EXPERIMENTAL
Intervention: Community events
Number of subjects: 568
Study 33582788 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal referrals
Number of subjects: 568
Study 36153559 — intervention group
Group type: EXPERIMENTAL
Intervention: Omitting routine intra-abdominal drainage after distal pancreatectomy (DP)
Number of subjects: 282
Study 36153559 — intervention group
Group type: COMPARATOR
Intervention: Routine intra-abdominal drainage after distal pancreatectomy (DP)
Number of subjects: 282
Study 33264094 — intervention group
Group type: EXPERIMENTAL
Intervention: ShoulderX
Number of subjects: 4
Study 33264094 — intervention group
Group type: EXPERIMENTAL
Intervention: Skelex
Number of subjects: 4
Study 33264094 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exoskeletons
Number of subjects: 4
Study 34351508 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) in a tumescent solution prior to liposuction
Number of subjects: 50
Study 34351508 — intervention group
Group type: COMPARATOR
Intervention: Traditional liposuction technique
Number of subjects: 50
Study 32976702 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic sleeve gastrectomy and robotic‐assisted kidney transplant
Number of subjects: 20
Study 32976702 — intervention group
Group type: COMPARATOR
Intervention: Robotic kidney transplant
Number of subjects: 20
Study 32337834 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplicated six-minute walk test (6MWT)
Number of subjects: 46
Study 33883288 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Walking
Number of subjects: 74
Study 33883288 — intervention group
Group type: COMPARATOR
Intervention: Conventional Walking
Number of subjects: 74
Study 33883288 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Nordic Walking and Conventional Walking
Number of subjects: 74
Study 35735417 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collection of a vaginal sample for HPV screening
Number of subjects: 13176
Study 35735417 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who agreed that screening with an HPV test instead of a Pap test was acceptable
Number of subjects: 13176
Study 35735417 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who indicated that collecting their own HPV sample was acceptable
Number of subjects: 13176
Study 35735417 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with higher educational ascertainment
Number of subjects: 13176
Study 33842978 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta Salud Diabetes (MSD) intervention delivered within support groups for 13 weeks
Number of subjects: 518
Study 33842978 — intervention group
Group type: COMPARATOR
Intervention: Control group (GAM usual care)
Number of subjects: 518
Study 32151879 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.65 g/kg alcohol
Number of subjects: 20
Study 32151879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32151879 — intervention group
Group type: EXPERIMENTAL
Intervention: Redundant multisensory signals
Number of subjects: 20
Study 32151879 — intervention group
Group type: EXPERIMENTAL
Intervention: Redundant unisensory signals
Number of subjects: 20
Study 35797844 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl chloride spray
Number of subjects: 202
Study 35797844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 33721359 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized muscle fatigue (induced by an isokinetic fatiguing protocol)
Number of subjects: 58
Study 33721359 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental fatigue (induced by the modified incongruent Stroop-word task)
Number of subjects: 58
Study 35733624 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP‐4 cream
Number of subjects: 199
Study 35733624 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac gel
Number of subjects: 199
Study 35730535 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual use of VERVE® Chews/Discs
Number of subjects: 213
Study 35730535 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive use of VERVE® Chews/Discs
Number of subjects: 213
Study 35730535 — intervention group
Group type: COMPARATOR
Intervention: Continue smoking (CS)
Number of subjects: 213
Study 32847403 — intervention group
Group type: EXPERIMENTAL
Intervention: MaxiPost (0.05 mg/min BKCa channel opener)
Number of subjects: 21
Study 32847403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 32847403 — intervention group
Group type: EXPERIMENTAL
Intervention: MaxiPost
Number of subjects: 21
Study 35925430 — intervention group
Group type: EXPERIMENTAL
Intervention: NOL-guided intraoperative administration of fentanyl
Number of subjects: 70
Study 33326678 — intervention group
Group type: EXPERIMENTAL
Intervention: Cruciate fascial incision
Number of subjects: 209
Study 33326678 — intervention group
Group type: COMPARATOR
Intervention: Circular incision
Number of subjects: 209
Study 33326678 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic mesh
Number of subjects: 209
Study 33326678 — intervention group
Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 209
Study 32149114 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope (MAC)
Number of subjects: 93
Study 32149114 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath video laryngoscope
Number of subjects: 93
Study 32149114 — intervention group
Group type: EXPERIMENTAL
Intervention: TruView PCD video laryngoscope
Number of subjects: 93
Study 34987033 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin (50 mg/kg body weight per dose, two times per day for 5 days)
Number of subjects: 3897
Study 34987033 — intervention group
Group type: COMPARATOR
Intervention: Control group (referral to health facility)
Number of subjects: 3897
Study 34987033 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximetry by CLHWs in intervention clusters
Number of subjects: 3897
Study 33877707 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 (1800 IU/day)
Number of subjects: 32
Study 33877707 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 32
Study 33877707 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose vitamin D3 (700 IU/day)
Number of subjects: 32
Study 32711853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose consumption at 15% of the acceptable daily intake using commercial sachets added to food
Number of subjects: 60
Study 32711853 — intervention group
Group type: COMPARATOR
Intervention: Control group followed the same protocol without an intervention
Number of subjects: 60
Study 34996629 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily teriparatide (TPTD) injections (20 μg)
Number of subjects: 27
Study 34996629 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly teriparatide (TPTD) injections (56.5 μg)
Number of subjects: 27
Study 34996629 — intervention group
Group type: COMPARATOR
Intervention: Standard conservative therapy (non-TPTD group)
Number of subjects: 27
Study 34668331 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 15 mg/kg intravenous TXA postoperatively at 2 and 24 hours after closing the incision (group A)
Number of subjects: 0
Study 34668331 — intervention group
Group type: EXPERIMENTAL
Intervention: A single dose of 15 mg/kg intravenous TXA 2 hours postoperatively (group B)
Number of subjects: 0
Study 34668331 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 0
Study 34593275 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-cm C-UCM
Number of subjects: 76
Study 34593275 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 76
Study 34547076 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-Dried Acellular Dermal Matrix (FDADM)
Number of subjects: 20
Study 34547076 — intervention group
Group type: EXPERIMENTAL
Intervention: Solvent-Dehydrated Acellular Dermal Matrix (SDADM)
Number of subjects: 20
Study 34547076 — intervention group
Group type: COMPARATOR
Intervention: Both FDADM and SDADM
Number of subjects: 20
Study 32157797 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg misoprostol
Number of subjects: 523
Study 32157797 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 μg misoprostol
Number of subjects: 523
Study 35483774 — intervention group
Group type: EXPERIMENTAL
Intervention: OKC
Number of subjects: 41
Study 36070924 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask with mask fitter
Number of subjects: 15
Study 36070924 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask with micropore tape
Number of subjects: 15
Study 36070924 — intervention group
Group type: COMPARATOR
Intervention: N95 mask
Number of subjects: 15
Study 36070924 — intervention group
Group type: COMPARATOR
Intervention: Surgical mask alone
Number of subjects: 15
Study 32302665 — intervention group
Group type: EXPERIMENTAL
Intervention: lixisenatide + basal insulin
Number of subjects: 150
Study 32302665 — intervention group
Group type: COMPARATOR
Intervention: sulphonylurea + basal insulin
Number of subjects: 150
Study 35839004 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention with personalized feedback for 6 months
Number of subjects: 307
Study 35839004 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 307
Study 34209561 — intervention group
Group type: EXPERIMENTAL
Intervention: FAWGT diet (fruit, avocado, whole grains, and trout)
Number of subjects: 44
Study 34209561 — intervention group
Group type: COMPARATOR
Intervention: Diet high in saturated fat and rich in processed carbohydrates
Number of subjects: 44
Study 35133634 — intervention group
Group type: EXPERIMENTAL
Intervention: m-health-based core stability exercise (CSE) combined with self-compassion training (SCT)
Number of subjects: 37
Study 35133634 — intervention group
Group type: COMPARATOR
Intervention: m-health-based core stability exercise (CSE) alone
Number of subjects: 37
Study 32285582 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified 5-step hand hygiene programme
Number of subjects: 472
Study 32285582 — intervention group
Group type: COMPARATOR
Intervention: Conventional 7-step hand hygiene programme
Number of subjects: 472
Study 32285582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 472
Study 34129830 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting frailty progression
Number of subjects: 3170
Study 36293799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (12-week reductive diet)
Number of subjects: 600
Study 36293799 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (12-week physical activity plan)
Number of subjects: 600
Study 36293799 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 600
Study 34697092 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression to dialysis
Number of subjects: 386
Study 34697092 — intervention group
Group type: COMPARATOR
Intervention: Stable advanced CKD
Number of subjects: 386
Study 34697092 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressed to dialysis
Number of subjects: 386
Study 36449869 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous irradiated polyglactin‐910 (IPG) sutures
Number of subjects: 210
Study 36449869 — intervention group
Group type: EXPERIMENTAL
Intervention: Nylon sutures
Number of subjects: 210
Study 36449869 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-absorbing gut (FG) sutures
Number of subjects: 210
Study 36449869 — intervention group
Group type: COMPARATOR
Intervention: Comparison among all suture materials (IPG, nylon, FG)
Number of subjects: 210
Study 34142743 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly exenatide-LAR injection with weekly nurse review for 20 weeks
Number of subjects: 22
Study 34142743 — intervention group
Group type: COMPARATOR
Intervention: Standard care with weekly nurse review for 20 weeks
Number of subjects: 22
Study 36049225 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinning exercise (group cycling with music)
Number of subjects: 45
Study 36049225 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary cycling (individual pedaling on a stationary bike)
Number of subjects: 45
Study 36049225 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 35189925 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSCs (106 UC-MSCs/kg, three intravenous infusions over 5 days)
Number of subjects: 45
Study 35189925 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl, three intravenous infusions over 5 days)
Number of subjects: 45
Study 35189925 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSCs
Number of subjects: 45
Study 35189925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 35749148 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial tear containing carbomer, hyaluronic acid, glycerol, and medium-chain triglycerides
Number of subjects: 32
Study 35749148 — intervention group
Group type: COMPARATOR
Intervention: Control artificial tears
Number of subjects: 32
Study 34656412 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC (hyperthermic intraperitoneal chemotherapy)
Number of subjects: 252
Study 34656412 — intervention group
Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 252
Study 32264945 — intervention group
Group type: EXPERIMENTAL
Intervention: Sahaj Samadhi Meditation
Number of subjects: 160
Study 32264945 — intervention group
Group type: COMPARATOR
Intervention: Health Enhancement Program
Number of subjects: 160
Study 35967847 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU-acquired infection
Number of subjects: 16808
Study 35967847 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on independent predictors
Number of subjects: 16808
Study 35967847 — intervention group
Group type: COMPARATOR
Intervention: Classical scoring systems (SIRS, SOFA, OASIS, SAPS II, LODS, CCI, APS III)
Number of subjects: 16808
Study 33309774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobimetinib plus atezolizumab
Number of subjects: 446
Study 33309774 — intervention group
Group type: COMPARATOR
Intervention: Pembrolizumab
Number of subjects: 446
Study 34452971 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol once daily (1.25-5 mg, dependent on tolerated dose)
Number of subjects: 1164
Study 34452971 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 1164
Study 35060333 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with lavender oil for 4 weeks
Number of subjects: 42
Study 35060333 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study 32449365 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS intervention for ARV retention and adherence
Number of subjects: 0
Study 32449365 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS intervention
Number of subjects: 0
Study 33087078 — intervention group
Group type: EXPERIMENTAL
Intervention: Piano instruction (experimental group)
Number of subjects: 155
Study 33087078 — intervention group
Group type: COMPARATOR
Intervention: Musical listening awareness (control group)
Number of subjects: 155
Study 35473344 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) decoction
Number of subjects: 120
Study 35473344 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine treatment
Number of subjects: 120
Study 33539664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting personalized post-recurrence survival (PRS)
Number of subjects: 376
Study 33539664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram's predictive capacity
Number of subjects: 376
Study 33539664 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk grouping by the nomogram
Number of subjects: 376
Study 33160281 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodiafiltration (HDF)
Number of subjects: 195
Study 33160281 — intervention group
Group type: COMPARATOR
Intervention: High-flux hemodialysis (HD)
Number of subjects: 195
Study 35724306 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment
Number of subjects: 3581
Study 32268897 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate (up to 3 g/day) for up to 2 years
Number of subjects: 300
Study 32268897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300